Add BrightSurf on Google Email

Science News for May 22, 2002


SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.

BioNumerik & Grelan present data on novel chemoprotecting agent

BP7787 shows impressive safety profile and high tumor response rate, indicating potential as a preventive measure for chemotherapy side effects. The Phase 1 clinical trial demonstrated no severe nerve damage and partial tumor remission in nearly all patients treated with BNP7787

SourceNoonan/Russo Communications·DateMay 22, 2002

Influenza infection attracts pneumonia bacteria

A study found that influenza A infection attracts pneumonia bacteria, increasing binding to lung epithelial cells. Treatment with Tamiflu may prevent this increased binding and related complications.

SourceAmerican Society for Microbiology·DateMay 22, 2002

New program helps protect Asian elephants through crop-raiding prevention

A new program helps protect Asian elephants from crop-raiding by implementing a coordinated effort to deter them, reducing farmer risk and protecting the environment. The initiative uses trip wires, sirens, spotlights, and firecrackers to scare off aggressive elephants, promoting coexistence between humans and wildlife.

SourceWildlife Conservation Society·DateMay 22, 2002
Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

Writing email about traumatic events can improve health

Researchers found that participants who wrote emails about traumatic emotional experiences were healthier in the weeks following their writings than those who wrote about non-emotional topics. The study's results suggest that written emotional expression is beneficial to physical health, even when conducted through email.

SourceTexas A&M University·DateMay 22, 2002

Calcium-dependent potassium channels as target to increase drug delivery to brain tumors

Researchers have identified a mechanism to increase drug delivery to brain tumors by manipulating calcium-dependent potassium channels. The study found that activating these channels can increase the permeability of the blood-brain tumor barrier, allowing cancer-killing medications to reach the tumor more effectively.

SourceCedars-Sinai Medical Center·JournalJournal of Pharmacology and Experimental Therapeutics·DateMay 22, 2002

Muscular dystrophy mouse model yields potential growth factor treatment

A new mouse model has shown promise in treating muscular dystrophy by increasing muscle mass and regeneration, reducing muscle cell death. The combination of better muscle regeneration and less muscle wasting could lead to improved muscle capacity over time.

SourceNIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases·DateMay 22, 2002

Insect yields clues to evolution of species

Researchers found that insects on the same plant were more likely to mate with each other than those on different plants, suggesting habitat plays a crucial role in speciation. The study provides evidence of host-plant adaptation driving reproductive isolation and repeated divergence in this species.

SourceUniversity of California - Santa Barbara·JournalNature·DateMay 22, 2002
AmScope B120C-5M Compound Microscope

AmScope B120C-5M Compound Microscope supports teaching labs and QA checks with LED illumination, mechanical stage, and included 5MP camera.

Hunger hormone may be key in weight loss

A recent study has found that low-calorie dieting raises ghrelin levels, while gastric bypass surgery sharply reduces them, making it a potential key to unlocking the secrets of successful weight loss. The research also suggests that this mechanism may be why gastric bypass surgery is often more effective than dieting.

SourceVeterans Affairs Research Communications·JournalNew England Journal of Medicine·DateMay 22, 2002

Study finds autoimmune link in juvenile Batten disease

Researchers discovered an autoimmune response to GAD65 enzyme leading to excess glutamate and brain damage in children with juvenile Batten disease. The study suggests immunotherapy may slow progression of the disease, which is fatal by late teens or twenties.

SourceNIH/National Institute of Neurological Disorders and Stroke·JournalHuman Molecular Genetics·DateMay 22, 2002